BIOMAT Database Logo BIOMAT Database Logo

Effects of propranolol on phosphatidate phosphohydrolase and mitogen-activated protein kinase activities in A7r5 vascular smooth muscle cells. 1998

K E Meier, and K C Gause, and A E Wisehart-Johnson, and A C Gore, and E L Finley, and L G Jones, and C D Bradshaw, and A F McNair, and K M Ella
Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston 29425-2251, USA. meierke@musc.edu

High doses of propranolol inhibit phosphatidate phosphohydrolase (PAP) activity in intact cells, thus blocking metabolism of phosphatidic acid (PA), product of the phospholipase D (PLD) reaction. Vasopressin and phorbol ester activate PLD and ERK (extracellular signal-regulated protein kinase) mitogen-activated protein kinases in A7r5, a rat vascular smooth muscle cell line. Propranolol increased PA levels in intact A7r5 cells and inhibited cytosolic PAP and membrane calcium-independent phospholipase A2 but did not activate PLD or enhance agonist-induced PA accumulation. Incubation of cells with 200 microM propranolol for 10-45 min markedly elevated PA but caused only partial activation of ERKs. Propranolol and other lipophilic amines caused a time- and dose-dependent detachment of cells from their substrate. These results confirm that elevation of PA is not a strong signal for ERK activation and emphasize that caution should be exercised in using propranolol as a PAP inhibitor in intact cells.

UI MeSH Term Description Entries
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D010711 Phosphatidate Phosphatase A phosphomonoesterase involved in the synthesis of triacylglycerols. It catalyzes the hydrolysis of phosphatidates with the formation of diacylglycerols and orthophosphate. EC 3.1.3.4. Phosphatidate Phosphohydrolase,Phosphatidic Acid Phosphatase,Phosphatidic Acid Phosphohydrolase,Phosphatase, Phosphatidate,Phosphatase, Phosphatidic Acid,Phosphohydrolase, Phosphatidate,Phosphohydrolase, Phosphatidic Acid
D010712 Phosphatidic Acids Fatty acid derivatives of glycerophosphates. They are composed of glycerol bound in ester linkage with 1 mole of phosphoric acid at the terminal 3-hydroxyl group and with 2 moles of fatty acids at the other two hydroxyl groups. Ammonium Phosphatidate,Diacylglycerophosphates,Phosphatidic Acid,Acid, Phosphatidic,Acids, Phosphatidic,Phosphatidate, Ammonium
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000318 Adrenergic beta-Agonists Drugs that selectively bind to and activate beta-adrenergic receptors. Adrenergic beta-Receptor Agonists,beta-Adrenergic Agonists,beta-Adrenergic Receptor Agonists,Adrenergic beta-Agonist,Adrenergic beta-Receptor Agonist,Betamimetics,Receptor Agonists, beta-Adrenergic,Receptors Agonists, Adrenergic beta,beta-Adrenergic Agonist,beta-Adrenergic Receptor Agonist,Adrenergic beta Agonist,Adrenergic beta Agonists,Adrenergic beta Receptor Agonist,Adrenergic beta Receptor Agonists,Agonist, Adrenergic beta-Receptor,Agonist, beta-Adrenergic,Agonist, beta-Adrenergic Receptor,Agonists, Adrenergic beta-Receptor,Agonists, beta-Adrenergic,Agonists, beta-Adrenergic Receptor,Receptor Agonist, beta-Adrenergic,Receptor Agonists, beta Adrenergic,beta Adrenergic Agonist,beta Adrenergic Agonists,beta Adrenergic Receptor Agonist,beta Adrenergic Receptor Agonists,beta-Agonist, Adrenergic,beta-Agonists, Adrenergic,beta-Receptor Agonist, Adrenergic,beta-Receptor Agonists, Adrenergic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013755 Tetradecanoylphorbol Acetate A phorbol ester found in CROTON OIL with very effective tumor promoting activity. It stimulates the synthesis of both DNA and RNA. Phorbol Myristate Acetate,12-Myristoyl-13-acetylphorbol,12-O-Tetradecanoyl Phorbol 13-Acetate,Tetradecanoylphorbol Acetate, 4a alpha-Isomer,12 Myristoyl 13 acetylphorbol,12 O Tetradecanoyl Phorbol 13 Acetate,13-Acetate, 12-O-Tetradecanoyl Phorbol,Acetate, Phorbol Myristate,Acetate, Tetradecanoylphorbol,Myristate Acetate, Phorbol,Phorbol 13-Acetate, 12-O-Tetradecanoyl,Tetradecanoylphorbol Acetate, 4a alpha Isomer
D014667 Vasopressins Antidiuretic hormones released by the NEUROHYPOPHYSIS of all vertebrates (structure varies with species) to regulate water balance and OSMOLARITY. In general, vasopressin is a nonapeptide consisting of a six-amino-acid ring with a cysteine 1 to cysteine 6 disulfide bridge or an octapeptide containing a CYSTINE. All mammals have arginine vasopressin except the pig with a lysine at position 8. Vasopressin, a vasoconstrictor, acts on the KIDNEY COLLECTING DUCTS to increase water reabsorption, increase blood volume and blood pressure. Antidiuretic Hormone,Antidiuretic Hormones,beta-Hypophamine,Pitressin,Vasopressin,Vasopressin (USP),Hormone, Antidiuretic,beta Hypophamine

Related Publications

K E Meier, and K C Gause, and A E Wisehart-Johnson, and A C Gore, and E L Finley, and L G Jones, and C D Bradshaw, and A F McNair, and K M Ella
Mitogen-activated protein kinase and proliferation of human vascular smooth muscle cells.
January 1996, The American journal of physiology,
K E Meier, and K C Gause, and A E Wisehart-Johnson, and A C Gore, and E L Finley, and L G Jones, and C D Bradshaw, and A F McNair, and K M Ella
Thrombin activates p38 mitogen-activated protein kinase in vascular smooth muscle cells.
March 2001, Life sciences,
K E Meier, and K C Gause, and A E Wisehart-Johnson, and A C Gore, and E L Finley, and L G Jones, and C D Bradshaw, and A F McNair, and K M Ella
Diverse effects of heparin on mitogen-activated protein kinase-dependent signal transduction in vascular smooth muscle cells.
July 1997, Circulation research,
K E Meier, and K C Gause, and A E Wisehart-Johnson, and A C Gore, and E L Finley, and L G Jones, and C D Bradshaw, and A F McNair, and K M Ella
Regulation of mitogen-activated protein kinase phosphatase-1 in vascular smooth muscle cells.
October 1998, Hypertension (Dallas, Tex. : 1979),
K E Meier, and K C Gause, and A E Wisehart-Johnson, and A C Gore, and E L Finley, and L G Jones, and C D Bradshaw, and A F McNair, and K M Ella
Regulation of mitogen-activated protein kinase by protein kinase C and mitogen-activated protein kinase phosphatase-1 in vascular smooth muscle.
June 2016, American journal of physiology. Cell physiology,
K E Meier, and K C Gause, and A E Wisehart-Johnson, and A C Gore, and E L Finley, and L G Jones, and C D Bradshaw, and A F McNair, and K M Ella
Propranolol, a phosphatidate phosphohydrolase inhibitor, also inhibits protein kinase C.
October 1992, The Journal of biological chemistry,
K E Meier, and K C Gause, and A E Wisehart-Johnson, and A C Gore, and E L Finley, and L G Jones, and C D Bradshaw, and A F McNair, and K M Ella
Effects of dehydroepiandrosterone on mitogen-activated protein kinase in human aortic smooth muscle cells.
January 1999, Life sciences,
K E Meier, and K C Gause, and A E Wisehart-Johnson, and A C Gore, and E L Finley, and L G Jones, and C D Bradshaw, and A F McNair, and K M Ella
Sphingosine induces phospholipase D and mitogen activated protein kinase in vascular smooth muscle cells.
December 1998, Biochemistry and molecular biology international,
K E Meier, and K C Gause, and A E Wisehart-Johnson, and A C Gore, and E L Finley, and L G Jones, and C D Bradshaw, and A F McNair, and K M Ella
Calponin and mitogen-activated protein kinase signaling in differentiated vascular smooth muscle.
October 1997, The Journal of biological chemistry,
K E Meier, and K C Gause, and A E Wisehart-Johnson, and A C Gore, and E L Finley, and L G Jones, and C D Bradshaw, and A F McNair, and K M Ella
Heparin inhibits mitogen-activated protein kinase activation in intact rat vascular smooth muscle cells.
September 1993, The Journal of biological chemistry,
Copied contents to your clipboard!